Stock Ratings from Analyst Ratings Network

Open Main Menu Open Sidebar

Sagent Pharmaceuticals Company Profile (NASDAQ:SGNT)

Consensus Ratings for Sagent Pharmaceuticals (NASDAQ:SGNT) (?)
Ratings Breakdown: 6 Hold Rating(s), 1 Buy Rating(s)
Consensus Rating:Hold (Score: 2.14)
Consensus Price Target: $28.29 (25.83% upside)

Analysts' Ratings History for Sagent Pharmaceuticals (NASDAQ:SGNT)
Show:
DateFirmActionRatingPrice TargetActions
4/7/2015Deutsche BankInitiated CoverageBuy -> Buy$29.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/20/2015RBC CapitalBoost Price TargetSector Perform$31.00 -> $34.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/17/2014Jefferies GroupLower Price TargetHold$33.00 -> $27.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/3/2014Jefferies GroupReiterated RatingHold$25.00 -> $33.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/31/2014RBC CapitalBoost Price TargetSector Perform$20.00 -> $27.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/31/2014JPMorgan Chase & Co.Boost Price TargetNeutral$24.00 -> $27.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/31/2014Jefferies GroupBoost Price TargetHold$23.00 -> $25.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/31/2014Needham & Company LLCDowngradeBuy -> Hold$25.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/25/2014S&P Equity ResearchDowngradeBuy -> Neutral$25.00 -> $28.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/25/2014Bank of AmericaDowngradeBuy -> Neutral$25.00 -> $28.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/15/2014Jefferies GroupReiterated RatingHold$23.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/7/2014JPMorgan Chase & Co.Reiterated RatingHold$22.00 -> $24.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/7/2014Jefferies GroupReiterated RatingHold$23.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/29/2014Jefferies GroupReiterated RatingHold$23.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/21/2014Jefferies GroupInitiated CoverageHold$23.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/12/2014JPMorgan Chase & Co.Reiterated RatingNeutral$24.00 -> $22.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/7/2014Bank of AmericaUpgradeNeutral -> Buy$26.00 -> $25.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/6/2014RBC CapitalInitiated CoverageUnderperform$22.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
9/11/2013RBC CapitalUpgradeSector Perform -> Outperform$22.00 -> $25.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/21/2013RBC CapitalBoost Price TargetSector Perform$19.00 -> $22.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/7/2013JPMorgan Chase & Co.Boost Price Target$18.00 -> $21.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/7/2013Jefferies GroupBoost Price TargetBuy$21.00 -> $27.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/7/2013Needham & Company LLCBoost Price TargetBuy$20.00 -> $25.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/3/2013Bank of AmericaReiterated RatingNeutral$19.00 -> $22.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 5/27/2013 forward)